Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin dose comparison for prevention of postoperative delirium after esophageal cancer surgery in older adults
ChiCTR2100054245Phase 4Recruiting
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of human insulin in postoperative delirium (POD) (3 arms), sponsored by General Hospital of Western Theater Command of PLA. Primary endpoints: Total incidence of postoperative delirium within 3 days, Serum TAU protein expression and 1 more. Started Jan 2022; status: recruiting.
02
Drugs
human insulin
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2100054245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054245.